Furthermore, a cross-sectional study involving 50 patients with AD demonstrated a significant association between elevated cerebrospinal orexin levels and reduced sleep duration, highlighting a potential role for orexin dysregulation in the progression of AD pathology, thereby confirming previous theories [90]. This evidence concerns the gene HCRT and Alzheimer disease.